BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2220941)

  • 21. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
    von Moers A; Danne T; Möller P; Scheffner D
    Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
    Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
    Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early endometriosis invades the extracellular matrix.
    Spuijbroek MD; Dunselman GA; Menheere PP; Evers JL
    Fertil Steril; 1992 Nov; 58(5):929-33. PubMed ID: 1426378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
    Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G
    Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
    Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
    Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive hormones and aminoterminal propeptide of type III procollagen in serum as early markers of pelvic pain during late pregnancy.
    Kristiansson P; Svärdsudd K; von Schoultz B
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):128-34. PubMed ID: 9914591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
    Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
    J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous evaluation of epithelial cell function by CA 125 and stromal cell activity by aminoterminal propeptide of type III procollagen (PIIINP) in ovarian carcinoma.
    Tomás C; Penttinen J; Risteli J; Risteli L; Kauppila A
    Ann Med; 1990 Apr; 22(2):115-21. PubMed ID: 2361007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
    Bolarin DM; Swerdlow P; Wallace AM; Littsey L
    Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
    Bolarin M
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
    Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
    Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings.
    Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
    Surgery; 1990 Apr; 107(4):381-8. PubMed ID: 2321135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
    Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
    Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
    Arrago JP; Poirier O; Najean Y
    Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary fibromyalgia: clinical parameters in relation to serum procollagen type III aminoterminal peptide.
    Jacobsen S; Jensen LT; Foldager M; Danneskiold-Samsøe B
    Br J Rheumatol; 1990 Jun; 29(3):174-7. PubMed ID: 2357497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
    Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
    Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
    Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
    Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH.
    Jensen LT; Jørgensen JO; Risteli J; Christiansen JS; Lorenzen I
    Acta Endocrinol (Copenh); 1991 Mar; 124(3):278-82. PubMed ID: 2011916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.